AstraZeneca in early talks to acquire Bristol Myers Squibb

Reports of preliminary takeover talks between AstraZeneca and Bristol Myers Squibb moved shares in both companies and reignited debate over consolidation in Big Pharma. A deal would mark a significant departure from the strategy AstraZeneca has followed for the past decade. No agreement has been confirmed.